NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The dispute over the cancellation of a coal mine comes as governments face hundreds of billions of dollars in exposure to claims from foreign investors over fossil fuel phaseouts.Read More